Bubs buys NuLac to drive expansion in domestic and China goat milk sector

By Cheryl Tay contact

- Last updated on GMT

The deal will give Bubs exclusive access to over 6 million litres of goat's milk every year. ©Getty Images
The deal will give Bubs exclusive access to over 6 million litres of goat's milk every year. ©Getty Images

Related tags: Milk

Bubs Australia has purchased NuLac Foods for $39m to further its plans for the infant and adult goat's milk product market in Australia and China.

The infant food manufacturer now has a near-50% share in NuLac's processing facilities, which includes a plant in Melbourne and a farm in west Gippsland.

NuLac also owns the Coach House Dairy and Caprilac brands, the latter of which produces goat's milk powder and yogurt for adults that are stocked by major supermarkets.

Other aspects of the deal include NuLac's IP and brands, sales and marketing, and the option to buy the Australian farm-operating company and its related goat farms.

Higher confidence, lower risk

Bubs CEO Nicholas Simms said that through this deal, Bubs will receive exclusive access to 6.2 million litres of milk yearly from approximately 8,500 goats in Australia and New Zealand.

He told Australian media, "Clearly, securing access to such an important key ingredient will increase market confidence and mitigate regulatory risk."

He added that Bubs' control of the goat herd milk supply was a "major strategic advantage"​ for the company, especially in terms of supply chain management.

Bullish on China growth

Regarding China, Simms said, "The combined strength of the organisations will deliver a highly compelling proposition and accelerate our collective growth in our domestic markets, and in China and South East Asia."

He also said the deal would give Bubs "an unrivalled provenance story"​, appealing to Chinese customers who tend to be especially interested in the source and domestic success of overseas products.

Already, despite China driving less than 25% of Bubs' sales, the company's growth rates in the country are nearly triple that of its domestic sales.

Busy with business

During a two-day trading freeze, Bubs raised $15m through an institutional share placement to fund the its purchase of NuLac; subsequently, Bubs' shares were reported to have risen by up to 8%.

The company resumed trading on Friday, buoyed by investor support of its business strategy. It intends to raise an additional $5m via a share purchase plan at 60 cents per share (matching the share price of its institutional share placement).

Currently, the Australian market accounts for 75% of Bubs' sales; the rest comes from overseas, with the Chinese market responsible for the bulk of its offshore sales.

Related news

Related products

CryoCap: Protecting Vit K2 in Mineral Combinations

CryoCap: Protecting Vit K2 in Mineral Combinations

NattoPharma USA, Inc. | 02-Sep-2019 | Technical / White Paper

Suppliers must deliver proven material they can assure is stable in any formulation. NattoPharma is that supplier.
Many parameters influence formulation...

Human Bifidobacteria, selected by Mother’s milk

Human Bifidobacteria, selected by Mother’s milk

Morinaga Milk Industry Co., Ltd. | 01-Feb-2019 | Technical / White Paper

Health promoting traits of Bifidobacteria are well-known around the world and its effect is strain-specific, however, whether the residential origin of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars